within Pharmacolibrary.Drugs.ATC.S;

model S01AA09
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.77,
    Cl             = 0.0005266666666666667,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0013,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0038333333333333336,
    Tlag           = 10.200000000000001
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>S01AA09</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Tetracycline is a broad-spectrum antibiotic from the tetracycline class, historically used to treat a variety of bacterial infections including respiratory tract infections, urinary tract infections, and acne. Its use has dramatically decreased due to resistance and the availability of newer agents, but it is still used in some settings.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult subjects after oral administration.</p><h4>References</h4><ol><li><p>Mergenhagen, KA, et al., &amp; Russo, TA (2020). Fact versus Fiction: a Review of the Evidence behind Alcohol and Antibiotic Interactions. <i>Antimicrobial agents and chemotherapy</i> 64(3) –. DOI:<a href=&quot;https://doi.org/10.1128/AAC.02167-19&quot;>10.1128/AAC.02167-19</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31871085/&quot;>https://pubmed.ncbi.nlm.nih.gov/31871085</a></p></li><li><p>Tao, RE, et al., &amp; Feldman, SR (2023). Oral Tetracycline-Class Drugs in Dermatology: Impact of Food Intake on Absorption and Efficacy. <i>Antibiotics (Basel, Switzerland)</i> 12(7) –. DOI:<a href=&quot;https://doi.org/10.3390/antibiotics12071152&quot;>10.3390/antibiotics12071152</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37508248/&quot;>https://pubmed.ncbi.nlm.nih.gov/37508248</a></p></li><li><p>Rodvold, KA, &amp; Pai, MP (2019). Pharmacokinetics and Pharmacodynamics of Oral and Intravenous Omadacycline. <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> 69(Suppl 1) S16–S22. DOI:<a href=&quot;https://doi.org/10.1093/cid/ciz309&quot;>10.1093/cid/ciz309</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31367744/&quot;>https://pubmed.ncbi.nlm.nih.gov/31367744</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end S01AA09;
